AmbiJet-assisted treatment for inflamed dental implants
Official title: Randomized, Controlled, Exploratory Study on the Treatment of Dental Implants Using the AmbiJet System for Peri-implantitis and Peri-implant Mucositis (AmbiJet-FIH)
Run by Freiburger Medizintechnik GmbH · NCT07722715 · Data updated 2026-11-12
This study tests whether applying cold atmospheric plasma with the AmbiJet system after standard cleaning helps reduce inflammation around dental implants more quickly in adults with peri-implant mucositis or peri-implantitis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 26 (estimated) |
| Sponsor | Freiburger Medizintechnik GmbH Industry-sponsored |
| Locations | 1 site (Romny) |
| Status | Recruiting |
| Started | February 14, 2026 |
| Main results expected | November 2026 |
| Study ends | November 20, 2026 |
| Registry record updated | July 24, 2026 |
| Trial ID | NCT07722715 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–65 with one to five implants showing peri-implant mucositis or peri-implantitis who have acceptable oral hygiene and meet the dental criteria.
✕Probably not a fit
Patients without inflammatory signs, with contraindicated materials, or with uncontrolled systemic conditions may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Patients with inflammation around dental implants receive conventional mechanical cleaning, plus an additional treatment with the AmbiJet cold plasma system to see if it safely accelerates resolution of inflammation. The trial will assess safety, tolerability, and clinical signs of inflammation after treatment. Participants are adults aged 18 to 65 with one to five implants showing mucositis or peri-implantitis, and follow-up considerations follow standard guidelines. The study is conducted under the Freiburger Medizintechnik sponsorship at a single research site.
Why it matters
Potential benefit: If successful, patients could experience faster reduction of gum inflammation around implants and potentially better implant survival.
How similar studies have gone: Prior data indicate peri-implant inflammation is common, but this specific CAP approach is novel and its effectiveness requires confirmation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: General criteria: * Men or women aged \>= 18 and \<= 65 years. * For women of childbearing age: a form of contraception recognized by conventional medicine during the study. * Written consent has been obtained from each patient for the study. Dental criteria: * Current X-ray of the implant region available (\<= 6 months prior to first treatment). * One to five implants with bone loss from the start of the part of the implant intended for osseointegration (X-ray findings). * Bleeding and/or suppuration after or without probing at the implant in question (peri-implant mucositis/peri-implantitis). * Clinical signs of inflammation (swelling, redness, soft tissue) on the implant in question (peri-implant mucositis/peri-implantitis). * Average oral hygiene (i.e., brushing teeth at least twice a day). Exclusion Criteria: General criteria: * Known allergies to materials used in the study (gold, copper, polyimide). * Diabetes (type I or type II), vasculitis, osteoporosis, osteomalacia. * Smokers (\>1 cigarette/week). * Use of medications to modulate bone metabolism (e.g., bisphosphonates). * Eating disorders such as bulimia or anorexia nervosa. * Use of antibiotics within the last 2 months prior to the start of the study. * Application of local antibiotics in the oral cavity within the last 2 months prior to the start of the study. * Use of antimicrobial mouthwashes within the last month before the start of the study. * Anti-inflammatory medication within the last month before the start of the study. * Pregnancy or breastfeeding. * Alcoholism or drug abuse. * Wound healing disorders. * Immunosuppression. * Condition following insertion of an electrical, electrically active, or electronic implant. Dental criteria: * An implant with bone loss \>6 mm from the start of the part of the implant intended for osseointegration (X-ray findings) (peri-implantitis). * Pathological changes in the oral mucosa or gingiva, such as oral lichen planus, chronic recurrent aphthae, melanotic macula, precancerous lesions (e.g., leukoplakia), melanomas. * Use of medically unacceptable types of treatment, therapies, or substances (off-label use of treatments for peri-implant mucositis or peri-implantitis).
Where it's running
-
LLC "Institute of Implantological Research
Romny, Ukraine Recruiting
Study contacts
- Study coordinator: Loic Ledernez, Phd
- Email: ledernez@frmed.de
- Phone: +49 176 96127565
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How Smoking Affects Immune Responses Around Dental Implants
This study tests how smoking changes the body's immune response around dental implants in people with healthy implants, peri-implant mucositis, or peri-implantitis.
-
Vitamin D and LL-37 Levels in Peri-Implant Fluids
This study tests whether levels of vitamin D in peri-implant fluids and the antimicrobial peptide LL-37 differ in people with dental implants who have mucositis or peri-implantitis.
-
Non-surgical treatment for gum disease's effect on blood vessel health
This study is testing whether a non-surgical gum treatment can improve blood vessel health in people with gum disease and healthy individuals.
-
Comparing immediate and delayed loading of zirconia dental implants
This study tests whether putting zirconia dental implants in right away or waiting a couple of months leads to better success for patients with missing teeth.
-
Treatment for peri-implantitis using implantoplasty
This study tests if adding implantoplasty to standard treatment helps people with peri-implantitis heal better than just the standard treatment alone.
-
Home-use dual-light antibacterial therapy for peri-implant mucositis around full-arch implants
This study tests whether a home-use dual-light device added to standard care can better control gum inflammation around full-arch dental implants than standard care alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.